Clinical Trial Update: Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing once-daily Tenofovir disoproxil fumarate/emtricitabine/efavirenz versus zidovudine/lamivudine with efavirenz in antiretroviral-naive HIV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• Emtriva (emtricitabine)
• Sustiva (efavirenz)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2010-10-13